Anixa Biosciences Inc Annual Net Cash Provided by (Used in) Operating Activities in USD from 2010 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Anixa Biosciences Inc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2010 to 2023.
- Anixa Biosciences Inc Net Cash Provided by (Used in) Operating Activities for the quarter ending January 31, 2024 was -$2.31M, a 16.1% decline year-over-year.
- Anixa Biosciences Inc annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$6.21M, a 4.36% increase from 2022.
- Anixa Biosciences Inc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$6.49M, a 31.5% decline from 2021.
- Anixa Biosciences Inc annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$4.94M, a 20% increase from 2020.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)